Association Between Work-Related Stress and Peripheral Neuropathic Pain in Female Breast Cancer Post CT
1 other identifier
observational
45
1 country
1
Brief Summary
This research aims to find the association between work-related stress and peripheral neuropathic pain in female breast cancer survivors post-chemotherapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2025
CompletedFirst Submitted
Initial submission to the registry
June 28, 2025
CompletedFirst Posted
Study publicly available on registry
July 9, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2025
CompletedJuly 9, 2025
June 1, 2025
3 months
June 28, 2025
June 28, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Douleur Neuropathique 4 (DN4) Questionnaire
The DN4 questionnaire is used to assess the neuropathic pain, if the score is \> 4 it indicates the neuropathic pain is present while \<3 than is unlikely.
6 Month
visual analog scale
The visual analog scale provide quantitative measurement of pain level which is from no pain to severe pain . The range of the scale is in between 0-10mm. 0-4 is consider as no pain, 5-44 is consider as mild pain,45-74 is moderate and \> 75 is consider as severe pain.
6 Months
Interventions
to find out the association between work-related stress and peripheral neuropathic pain in female breast cancer survivors post-chemotherapy.
Eligibility Criteria
to find out the Association Between Work-Related Stress and Peripheral Neuropathic Pain in Female Breast Cancer
You may qualify if:
- Females who have completed chemotherapy at least o1 year prior to study.
- Aged 29-51.
- Females who is currently employed.
- Females who have done chemotherapy for stage 1,2,3.
- Females who underwent chemotherapy cycles 6-8.
- Females who are willing to participate in the study
You may not qualify if:
- Females suffering from psychiatric conditions such as anxiety and depression.
- Females suffering from diabetes.
- Females who have active cancer.
- Females with mastectomy.
- Absent from treatment for more than 2 weeks will be excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Lahore City
Lahore, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 28, 2025
First Posted
July 9, 2025
Study Start
March 3, 2025
Primary Completion
June 1, 2025
Study Completion
September 1, 2025
Last Updated
July 9, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share